DXN Direct Bilirubin Reagent - Taiwan Registration 204f7700a6e01ba04df004a6a5c2fa02
Access comprehensive regulatory information for DXN Direct Bilirubin Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 204f7700a6e01ba04df004a6a5c2fa02 and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH. The authorized representative in Taiwan is TUNYEN ENTERPRISE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
In vitro diagnostic reagents for the quantitative determination of direct bilirubin in serum or plasma on a photometric system.
A Clinical chemistry and clinical toxicology
A.1110 Bilirubin (total or direct) test system
Input;; QMS/QSD
Dates and Status
Dec 30, 2021
Dec 30, 2026